nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—Oesophageal stenosis—Riluzole—amyotrophic lateral sclerosis	0.0896	0.185	CcSEcCtD
Alendronate—FDPS—jaw skeleton—amyotrophic lateral sclerosis	0.0724	0.143	CbGeAlD
Alendronate—PTPN4—hindbrain—amyotrophic lateral sclerosis	0.0476	0.0939	CbGeAlD
Alendronate—PTPRS—hindbrain—amyotrophic lateral sclerosis	0.0408	0.0805	CbGeAlD
Alendronate—Gastrointestinal tract irritation—Riluzole—amyotrophic lateral sclerosis	0.0388	0.0801	CcSEcCtD
Alendronate—PTPN4—brainstem—amyotrophic lateral sclerosis	0.0273	0.0538	CbGeAlD
Alendronate—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0271	0.0559	CcSEcCtD
Alendronate—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.0238	0.0492	CcSEcCtD
Alendronate—ATP6V1A—hindbrain—amyotrophic lateral sclerosis	0.0235	0.0464	CbGeAlD
Alendronate—PTPRS—brainstem—amyotrophic lateral sclerosis	0.0234	0.0461	CbGeAlD
Alendronate—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.0199	0.0412	CcSEcCtD
Alendronate—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0356	CcSEcCtD
Alendronate—PTPRE—nervous system—amyotrophic lateral sclerosis	0.015	0.0297	CbGeAlD
Alendronate—ATP6V1A—embryo—amyotrophic lateral sclerosis	0.0147	0.029	CbGeAlD
Alendronate—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0303	CcSEcCtD
Alendronate—PTPRS—spinal cord—amyotrophic lateral sclerosis	0.0145	0.0287	CbGeAlD
Alendronate—PTPRE—central nervous system—amyotrophic lateral sclerosis	0.0145	0.0285	CbGeAlD
Alendronate—PTPN4—nervous system—amyotrophic lateral sclerosis	0.0143	0.0282	CbGeAlD
Alendronate—PTPRE—cerebellum—amyotrophic lateral sclerosis	0.0141	0.0279	CbGeAlD
Alendronate—PTPN4—central nervous system—amyotrophic lateral sclerosis	0.0138	0.0272	CbGeAlD
Alendronate—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0135	0.028	CcSEcCtD
Alendronate—ATP6V1A—brainstem—amyotrophic lateral sclerosis	0.0135	0.0266	CbGeAlD
Alendronate—PTPN4—cerebellum—amyotrophic lateral sclerosis	0.0134	0.0265	CbGeAlD
Alendronate—PTPRS—nervous system—amyotrophic lateral sclerosis	0.0122	0.0242	CbGeAlD
Alendronate—PTPRS—central nervous system—amyotrophic lateral sclerosis	0.0118	0.0233	CbGeAlD
Alendronate—PTPRS—cerebellum—amyotrophic lateral sclerosis	0.0115	0.0227	CbGeAlD
Alendronate—PTPRE—brain—amyotrophic lateral sclerosis	0.0115	0.0227	CbGeAlD
Alendronate—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0237	CcSEcCtD
Alendronate—PTPN4—brain—amyotrophic lateral sclerosis	0.0109	0.0216	CbGeAlD
Alendronate—ATP6V1A—medulla oblongata—amyotrophic lateral sclerosis	0.0094	0.0186	CbGeAlD
Alendronate—PTPRS—brain—amyotrophic lateral sclerosis	0.00936	0.0185	CbGeAlD
Alendronate—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0089	0.0184	CcSEcCtD
Alendronate—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00875	0.0181	CcSEcCtD
Alendronate—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00869	0.018	CcSEcCtD
Alendronate—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00869	0.018	CcSEcCtD
Alendronate—ATP6V1A—spinal cord—amyotrophic lateral sclerosis	0.00838	0.0165	CbGeAlD
Alendronate—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00833	0.0172	CcSEcCtD
Alendronate—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00794	0.0164	CcSEcCtD
Alendronate—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00756	0.0156	CcSEcCtD
Alendronate—FDPS—medulla oblongata—amyotrophic lateral sclerosis	0.00708	0.014	CbGeAlD
Alendronate—ATP6V1A—nervous system—amyotrophic lateral sclerosis	0.00706	0.0139	CbGeAlD
Alendronate—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00699	0.0144	CcSEcCtD
Alendronate—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0144	CcSEcCtD
Alendronate—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00686	0.0142	CcSEcCtD
Alendronate—ATP6V1A—central nervous system—amyotrophic lateral sclerosis	0.0068	0.0134	CbGeAlD
Alendronate—ATP6V1A—cerebellum—amyotrophic lateral sclerosis	0.00665	0.0131	CbGeAlD
Alendronate—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00658	0.0136	CcSEcCtD
Alendronate—FDPS—spinal cord—amyotrophic lateral sclerosis	0.00631	0.0125	CbGeAlD
Alendronate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00615	0.0127	CcSEcCtD
Alendronate—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00597	0.0123	CcSEcCtD
Alendronate—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00593	0.0123	CcSEcCtD
Alendronate—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00582	0.012	CcSEcCtD
Alendronate—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00562	0.0116	CcSEcCtD
Alendronate—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0056	0.0116	CcSEcCtD
Alendronate—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00554	0.0114	CcSEcCtD
Alendronate—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00546	0.0113	CcSEcCtD
Alendronate—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00544	0.0112	CcSEcCtD
Alendronate—ATP6V1A—brain—amyotrophic lateral sclerosis	0.0054	0.0107	CbGeAlD
Alendronate—FDPS—nervous system—amyotrophic lateral sclerosis	0.00532	0.0105	CbGeAlD
Alendronate—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00516	0.0107	CcSEcCtD
Alendronate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00516	0.0107	CcSEcCtD
Alendronate—FDPS—central nervous system—amyotrophic lateral sclerosis	0.00512	0.0101	CbGeAlD
Alendronate—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0051	0.0105	CcSEcCtD
Alendronate—FDPS—cerebellum—amyotrophic lateral sclerosis	0.00501	0.00988	CbGeAlD
Alendronate—Infection—Riluzole—amyotrophic lateral sclerosis	0.00491	0.0101	CcSEcCtD
Alendronate—Risedronate—PTGS2—amyotrophic lateral sclerosis	0.00479	0.529	CrCbGaD
Alendronate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0045	0.0093	CcSEcCtD
Alendronate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00899	CcSEcCtD
Alendronate—Clodronate—PTGS2—amyotrophic lateral sclerosis	0.00427	0.471	CrCbGaD
Alendronate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00873	CcSEcCtD
Alendronate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00873	CcSEcCtD
Alendronate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00841	CcSEcCtD
Alendronate—FDPS—brain—amyotrophic lateral sclerosis	0.00407	0.00803	CbGeAlD
Alendronate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00835	CcSEcCtD
Alendronate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00811	CcSEcCtD
Alendronate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00807	CcSEcCtD
Alendronate—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00807	CcSEcCtD
Alendronate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00752	CcSEcCtD
Alendronate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00733	CcSEcCtD
Alendronate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00722	CcSEcCtD
Alendronate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00699	CcSEcCtD
Alendronate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00675	CcSEcCtD
Alendronate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00649	CcSEcCtD
Alendronate—Rash—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00644	CcSEcCtD
Alendronate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00643	CcSEcCtD
Alendronate—Headache—Riluzole—amyotrophic lateral sclerosis	0.0031	0.0064	CcSEcCtD
Alendronate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00606	CcSEcCtD
